Dulce Garrido

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index561citations29works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(7), Diabetes Treatment and Management(4), HIV/AIDS drug development and treatment(4), Ion channel regulation and function(3), RNA Research and Splicing(3)

Publications29 total

Estética basada en células madre: integración de la ciencia regenerativa con la ética centrada en el paciente
Educational Regent Multidisciplinary Journal·2025Open Access
Next-Generation Aesthetic Surgery: Regenerative Approaches and Ethical Challenges
International Science Journal·2025Open Access
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein
Bioorganic & Medicinal Chemistry Letters·2014· 28 cited
CCDC 970777: Experimental Crystal Structure Determination
The Cambridge Structural Database·2014Open Access
CCDC 970778: Experimental Crystal Structure Determination
The Cambridge Structural Database·2014Open Access
Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
Journal of Medicinal Chemistry·2012· 54 cited
HIV-1 Reverse Transcriptase in complex with inhibitor GSK952
2012
HIV-1 Reverse Transcriptase in complex with inhibitor GSK500
2012
HIV-1 Reverse Transcriptase Y188L mutant in complex with inhibitor GSK560
2012
Imidazo[1,2- <i>a</i> ]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization
ACS Medicinal Chemistry Letters·2012· 47 citedOpen Access
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy
Bioorganic & Medicinal Chemistry Letters·2008· 20 citedOpen Access
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups
Bioorganic & Medicinal Chemistry Letters·2008· 7 citedOpen Access
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues
Bioorganic & Medicinal Chemistry Letters·2008· 7 citedOpen Access
A Novel One‐Pot Synthesis of N‐Substituted Thieno[3,2‐d]pyrimidin‐4(3H)‐ones
ChemInform·2007
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist
Journal of Medicinal Chemistry·2006· 20 citedOpen Access
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
Bioorganic & Medicinal Chemistry Letters·2006· 47 citedOpen Access
Synthesis and Activity of Small Molecule GPR40 Agonists.
ChemInform·2006· 1 cited
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3
Bioorganic & Medicinal Chemistry Letters·2006· 46 citedOpen Access
Synthesis and activity of small molecule GPR40 agonists
Bioorganic & Medicinal Chemistry Letters·2006· 109 citedOpen Access
A Novel One-Pot Synthesis of N-Substituted Thieno[3,2-d]pyrimidin-4(3H)-ones
Heterocycles·2006· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Andrew J. Peat(24), Stephen A. Thomson(10), Scott H. Dickerson(7), Robert T. Nolte(6), Joyce A. Boucheron(5), Tony Y. Wang(5), Amanda Mathis(5), Francis X. Tavares(5), Aaron S. Goetz(4), Terrence L. Smalley(4), Stephanie L. Schweiker(4), Pek Y. Chong(4), Paul R. Sebahar(4), Michael Youngman(4), Eugene L. Stewart(4), Robert G. Ferris(4), Kurt Weaver(4), Katrina L. Creech(4), Jeffrey J. Pouliot(4), John W. Seal(4)